Secrest Blakey & Associates’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,192
Closed -$675K 69
2019
Q3
$675K Buy
3,192
+129
+4% +$27K 0.56% 52
2019
Q2
$595K Buy
3,063
+84
+3% +$15.5K 0.52% 59
2019
Q1
$490K Sell
2,979
-1,400
-32% -$248K 0.48% 59
2018
Q4
$829K Buy
+4,379
New +$809K 0.69% 45
2018
Q3
Sell
-4,624
Closed -$758K 110
2018
Q2
$758K Buy
4,624
+214
+5% +$35K 0.6% 49
2018
Q1
$713K Buy
4,410
+72
+2% +$11.5K 0.61% 47
2017
Q4
$644K Buy
+4,338
New +$618K 0.52% 56

Other funds holding CME

Secrest Blakey & Associates's CME Position: Q4 2019 in Review

Secrest Blakey & Associates sold out of CME Group (CME) in Q4 2019, closing a stake of 3,192 shares — an estimated $675K sold.

Secrest Blakey & Associates first reported a position in CME in Q4 2017 and held it in 7 quarters. The position peaked at $829K in Q4 2018. 1,060 funds tracked by Wall St. Rank hold CME as of Q4 2019.

  • Secrest Blakey & Associates reported no remaining CME Group position as of Q4 2019 after selling out during the quarter.
  • Secrest Blakey & Associates sold 3,192 CME Group shares in Q4 2019, an estimated $675K.
  • Secrest Blakey & Associates first reported a position in CME Group in Q4 2017 and held it in 7 quarters.
  • Secrest Blakey & Associates's CME Group position peaked at $829K in Q4 2018.
  • 1,060 funds tracked by Wall St. Rank held CME Group as of Q4 2019.

Based on Secrest Blakey & Associates's 13F filing for Q4 2019, filed 5 Feb 2020.